Immune Regulation: Funding, Investors & Team (Sep 2026)
Immune Regulation is a clinical-stage biotech company pioneering new technologies for resetting the immune system for long-term remission.
Immune Regulation has raised $52.2M across 1 funding round on record, the most recent an undisclosed round of $52.2M announced in Sep 2020.
That round is above the $4.0M median round size for United Kingdom companies tracked on FundedIQ over the last two years.
Immune Regulation Company Profile and Key Stats
Latest funding round on record: Sep 2020.
Immune Regulation Funding Rounds
Immune Regulation Founders and Leadership Team
Contact details for the Immune Regulation team: 1 of 1 has an email address on file.
Start 14-day free trial →Immune Regulation Funding in Context
Immune Regulation's latest round of $52.2M is above the median round in United Kingdom. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Immune Regulation in Biotechnology and Cambridge
Companies Similar to Immune Regulation
Hopstem is a pharmaceutical company engaged in human iPSCs/ESCs neural differentiation, cell banking, and…
Novellusdx develops tumor specific driver mutations.
RFC Power develops grid-scale long-duration energy storage technology for renewable power systems.
RT BIO SYSTEMS specializes in biotechnological research, manufacture, and B2B supply of health supplements…
Breedr is a productivity and marketing platform that’s transforming the livestock supply-chain.
TRIVER offers immediate funding to small businesses with just a single click. By utilizing Open Banking data…
Itoflow is an AI-native platform providing institutional-grade, automated quantitative research and portfolio…
Axiom Therapeutics is a health tech company that provides computational drug discovery solutions for…
Stability AI is developing open AI resources that enable us to maximize our capabilities. We create and…
Boldr develops smart HVAC products and software designed for contractors and their customers.
Embedd is a software product company that offers developer tools for embedded software development.
Verascient connects your tools, builds a context graph, and surfaces it to agents.
Immune Regulation Funding FAQs
What does Immune Regulation do?
Immune Regulation is a clinical-stage biotech company pioneering new technologies for resetting the immune system for long-term remission.
How much funding has Immune Regulation raised?
Immune Regulation has raised $52.2M across 1 round on record. The most recent is an undisclosed round of $52.2M announced in Sep 2020.
When did Immune Regulation last raise funding?
Immune Regulation's most recent funding round on record is an undisclosed round of $52.2M, announced in Sep 2020.
Who is the CEO of Immune Regulation?
Jonathan Rigby is listed as CEO at Immune Regulation.
Where is Immune Regulation headquartered?
Immune Regulation is based in Cambridge, N/A, United Kingdom.
How many employees does Immune Regulation have?
Immune Regulation is in the 11-50 employee band.
About FundedIQ's Immune Regulation Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Immune Regulation is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.